CRISPR THERAPEUTICS AG (CRSP)
CH0334081137 - Common Stock
This Beaten-Down Biotech Stock Just Got Some Good News: Time to Buy?
Interesting CRSP Put And Call Options For February 2025
1 big new Green Flag for CRISPR Therapeutics' Stock
Is Vertex Stock A Sell After Pain Drug Whiffs In Midstage Study?
The company is still planning to move into Phase 3 testing, but analysts doubt the pain drug's future.
2 Growth Stocks That Could Rocket Higher in 2025: Are They Right for Your Portfolio?
3 Things You Need to Know if You Buy CRISPR Therapeutics Today
CRISPR Therapeutics Presents Data at the 2024 American Society of Hematology (ASH) Annual Meeting
-Preliminary data demonstrate that CTX112™ has the potential to provide meaningful clinical benefit with a well-tolerated safety profile using a standard...
2 Biotech Stocks to Buy Hand Over Fist in December
The biotech industry has lagged the broader market so far in 2024. The SPDR S&P Biotech ETF, an industry benchmark, is up 9% this year compared to 28% for the S&P 500. Despite moving in opposite directions in 2024, CRISPR Therapeutics and Exelixis have strong prospects.
2 Biotech Stocks to Buy Hand Over Fist in December
January 2025 Options Now Available For CRISPR Therapeutics (CRSP)
3 of the Best Growth Stocks You Can Buy for Less than $100
Meet the Beaten-Down Biotech Stock Cathie Wood Loves and Wall Street Says May Soar More than 65%
Down 47% Since March, Is CRISPR Therapeutics Stock a Buy on the Dip?
3 Monster Stocks in the Making
2 Top Biotech Stocks to Buy Now and Hold For 5 Years or More
First Week of July 2025 Options Trading For CRISPR Therapeutics (CRSP)
Where Will CRISPR Therapeutics Be in 3 Years?
CRISPR Therapeutics to Present at the Jefferies London Healthcare Conference
ZUG, Switzerland and BOSTON, Nov. 14, 2024 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating...
3 Unstoppable Growth Stocks I'm Loading $25,000 Each Into by 2029
These three emerging technology leaders are pioneering quantum computing, gene editing, and electric aviation.
Bullish Two Hundred Day Moving Average Cross - CRSP
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought
The rock star fund investor made a lot of big moves on Thursday.
CRISPR Therapeutics Provides Business Update and Reports Third Quarter 2024 Financial Results
-CASGEVY™ approved for the treatment of patients 12 years of age and older with sickle cell disease (SCD) and transfusion-dependent beta thalassemia (TDT)...
3 Companies Building Tomorrow's Game-Changing Technologies
These pioneering companies are transforming delivery, medicine, and space access--potentially creating massive opportunities for early investors.
Thinking of Buying CRISPR Therapeutics Stock? Watch These 2 Key Numbers
It won't be able to be profitable without hitting its targets for both of these figures.
12 High-Growth Stocks That Could Deliver Parabolic Returns
These 12 innovative companies could deliver exponential returns over the next quarter century.
The Ultimate Biotech Stock to Buy With $50 Right Now
This company might be worth far more than many realize.
Interesting CRSP Put And Call Options For December 6th
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought
The aggressive growth icon kicked off the new trading week by buying some of her favorite stocks.
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought
The aggressive growth icon kicked off the new trading week by buying some of her favorite stocks.
Why We Buy Stocks
Is fear of missing out (FOMO) controlling your portfolio?
3 Bargain Stocks to Buy in a Market That's Priced for Perfection
Yes, bargains can still be found in the stock market.
Why I Keep Buying These 14 Incredible Growth Stocks
This diverse set of growth stocks offers tremendous opportunities in the fields of AI, space, biotech, and emerging industries.
Is CRISPR Therapeutics Stock a Buy?
The markets this biotech is looking to enter could be extremely lucrative.
2 Biotech Stocks That Are Screaming Buys This Month
They won't remain southbound forever.